期刊文献+

血管抑素抗肿瘤治疗的研究现状 被引量:1

下载PDF
导出
摘要   药物抗肿瘤血管生成作为一种新颖的肿瘤治疗手段,一直是研究的热点.而血管抑素作为最先发现的肿瘤源性血管生成抑制因子,更是研究的重点.……
出处 《重庆医科大学学报》 CAS CSCD 2006年第z1期33-35,共3页 Journal of Chongqing Medical University
  • 相关文献

参考文献15

  • 1[1]Folkman J.Tumor angiogenesis:therapeutic implications[J].NewEnsl J Med,1971; 285:1182-1186.
  • 2[2]Hamhan D,Folkman J.Pattems and emc,si mechanisms Ofthemlg switch dIlriIlgturaorigenesis[J].Cel,1996;86:353-364.
  • 3陈飞虎.肿瘤血管生成抑制因子及Endostatin研究进展[J].安徽医药,2003,7(1):5-7. 被引量:9
  • 4[4]Chi sl,Pizzo SV.Angiostatin is directly cytotoxic to tumor cells at low extracellular pH:a mechanism dependent on cell surface-associated ATP synthase[J].Cancer Res,2006;66(2):875-882.
  • 5[5]Dirkx AE.Anti-angiostatin therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors[J]Faseb J.2006;20(6):621-630.
  • 6[6]Chen YH.Wu HL.Anti-angiogenesis mediated by angiostatin K1-3,K1-4 and K1-4.5.Involvement of p53,FasL,AKT and mRNA deregulation[J].Thromb Haemost,2006;95(4):668-677.
  • 7[7]YOUN MR,park MH.Direct binding of recombinant plasminogen kringle1-3 to angiogenin inhibits angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM[J].Biochem Biophys Res Commun,2006;343(3):917-923.
  • 8[8]Schmidt K Angiostatin overexpression in morris hepatoma results in decreased tumor growth but increased perfusion and vascularization[J].Nucl Med,2006;47(3):543-551.
  • 9[9]Dudani AK.Angiostatin and plasminogen share binding to endothelial cell surface actin[J].Biochem Cell Biol,2005;83(1):28-35.
  • 10[10]Kim KS.Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by hydrodynamics-based transfection method[J].Oncol Res,2005;15(7-8):343-350.

二级参考文献18

  • 1[1]OReilly MS, Holmgren L, Shing Y et al. Angiostatin:A novel angiogenesis inhibitor that mediates the suppression of metasta ses by a Lewis lung carcinoma, Cell, 1994;79(2) :315~28
  • 2[2]OReilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth, Cell, 1997;88 (2):277~85
  • 3[3]Standker L, Schrader M, Kanse SM et al. Isolation and charac terization of the circulating from of human endostatin, FEBSLett, 1997;420(2~3) :129~33
  • 4[4]Ferreras M, Felbor U, Lenhard T et al. Generation and degradation of human endostatin proteins by variors proteinases. FEBS Lett, 2000 ;486(3) :247~51
  • 5[5]Iughetti P, Suzuki O, Godoi PHC et al. A polymorphism in en dostatin, an angigenesis inhibitor, predisposes for the development of prostatic adenocarcinoma. Cancer Res, 2001; 61 (20): 7375~8
  • 6[6]Miosge N, Sasaki T, Timpl R. Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. Faseb J, 1999;13(13) :1743~50
  • 7[7]Annual meeting, American society of clinical oncology (ASCO), May, 2001. San Francisco of California
  • 8[8]Kasai S, Nagasawa H, Shimamura M et al. Design and synthesis of antiangiogenic/heparin-binding arginine dendrimer mimicking the surface of endostatin. Bioorganic & Medicinal Chemistry Letters, 2002 ; 12:951 ~ 4
  • 9[9]Hohenester E,Sasaki T ,Mann K et al. Variable zinc coordination in endostatin. J Mol Biol, 2000; 297 (1): 1 ~ 6
  • 10[10]Yamaguchi N, Anand-Apte B, Lee Metal. Endostatin inhibits VEGF-induced endothelial cell migration and rumor growth inde pendently of zinc binding. The EMBO J, 1999; 18(16) :4414~23

共引文献8

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部